Choongwae to launch a new drug for anti-cholesterol markets.

Choongwae launched Rivaro tablet, a new anti-cholesterol drug (Pitavastatin) on July 1, which was jointly developed by Japanese Kowa and Nissan Chemical having excellent efficacy and safety profiles.

According to the clinical studies conducted at Seoul National University and Shinchon Severance hospitals, Rivaro 2mg reduces LDL cholesterol by more than 40% at such a low dose and increases HD...